BVDV-IN-1 NEW
| Price | $34 | $83 | $133 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-10 |
Product Details
| Product Name: BVDV-IN-1 | CAS No.: 345651-04-9 |
| Purity: 98.93% | Supply Ability: 10g |
| Release date: 2025/11/10 |
Product Introduction
Bioactivity
| Name | BVDV-IN-1 |
| Description | BVDV-IN-1 is a non-nucleoside inhibitor (NNI) of bovine viral diarrhea virus (BVDV) with an EC50 of 1.8 μM, directly binding to a hydrophobic pocket of the BVDV RdRp, and demonstrating antiviral activity against BVDV resistant to NNI thiosemicarbazone (TSC). |
| In vitro | BVDV-IN-1?has antiviral activity against BVDV resistant to NNI thiosemicarbazone (TSC). It is a non-nucleoside inhibitor (NNI) of bovine viral diarrhea virus (BVDV), with an EC50 of 1.8 μM. It directly binds to a hydrophobic pocket of the BVDV RdRp. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5 mg/mL (14.95 mM), Sonication is recommended. DMSO : 250 mg/mL (747.59 mM), Sonication is recommended. |
| Keywords | virus | viral | RNASynthesis | RNA Synthesis | non-nucleoside | inhibitor | inhibit | DNASynthesis | DNA/RNA Synthesis | DNA Synthesis | diarrhea | BVDV-IN-1 | BVDVIN1 | BVDV IN 1 | bovine | antiviral | activity |
| Inhibitors Related | 5-Fluorouracil | Quinizarin | Adenine hemisulfate | Rifaximin | Guanidine hydrochloride | Methotrexate disodium | Adenine | Penicillin G potassium | (E)-3-(p-Tolyl)acrylaldehyde | Carbazole | Thymidine | Docosanoic acid |
| Related Compound Libraries | DNA Damage & Repair Compound Library | Bioactive Compound Library | Anti-Viral Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | NO PAINS Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Cell Cycle Compound Library | Anti-Infection Compound Library | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $195.00/1mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-11-10 | |
| $2.00/100kg |
VIP1Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2025-06-19 | |
| $1980.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-10-27 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY